CST in collaboration with Paladin Labs Inc. and Astellas Pharma Canada Inc. are proud to announce the return of Transformative Thinking in Transplant (T3) Competition, to be held on October 15, 2024.
In the next generation of the T3 series of grants, the objective of this competition entitled the 2024 CST T3 Grant Competition in Transplantation and Donation is to support clinical research studies aimed at improving patient outcomes and quality of life. Clinical research may include studies on treatment, prevention, diagnostics, natural history, behavioral studies, health economics, epidemiology, or quality improvement. Quantitative and qualitative methodologies are included. Three finalists will be invited to present their ideas at a live event on October 15, 2024. As ranked by the live audience, the top finalist will be awarded $50,000 and the second and third-ranked finalists will each receive an award in the amount of $25,000.
Have an idea that could revolutionize transplant care in Canada?
Do not delay submit your application today. A letter of intent is required by June 14, 2024, with a deadline application of July 18, 2024.
Learn more here!